Advertisement
Organisation › Details
Gründerfonds Ruhr GmbH & Co. KG
Jointly initiated by Initiativkreis Ruhr and NRW.BANK, Gruenderfonds Ruhr is the first private-sector early-stage fund in the Ruhr region to be financed by regional industrial and financial companies. The fund invests in innovative and technology-oriented companies in the life science & health, digital economy, chemicals & new materials, energy & industry and logistics & trade sectors. Good growth and exit prospects as well as competent management are prerequisites. As a multi-corporate early-stage fund Gruenderfonds Ruhr also opens up important industry access opportunities for the respective portfolio companies. *
Start | 2019-10-15 existent | |
Group | Nordrhein-Westfalen (govt region) | |
Industry | venture capital | |
Industry 2 | business development (state/region) | |
Person | Nastos, Aristotelis (North Rhine-Westphalia 202107 Head Life Sciences+Cleantech NRW.Bank before Creathor + NRW.Bank) | |
Region | Essen | |
Country | Germany | |
Street | 8 Theaterplatz | |
City | 45127 Essen | |
Tel | +49-201-8115-115 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Nordrhein-Westfalen (govt region)
- [1] Ningaloo Biosystems GmbH. (6/22/22). "Press Release: Ningaloo’s Opto-Bioproduction Platform Gets Boost from Investors". Cologne....
- [2] ECBF Management GmbH. (10/13/21). "Press Release: Investing in a Greener Future. European Sustainability Fund ECBF Raises over EUR 200 Million". Luxembourg....
- [3] Cevec Pharmaceuticals GmbH. (7/27/21). "Press Release: Cevec Closes Growth Financing Round to Serve Strong Demand in Viral Vector Technologies for Cell and Gene Therapies". Cologne....
- [4] Ubirch GmbH. (3/6/20). "Press Release: Cologne-based Blockchain-anchored Data Security Start-up Ubirch Completes Third Round of Financing"....
- [5] Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen....
- [6] MLM Medical Labs GmbH. (4/2/17). "Press Release: MLM Welcomes Annette Angenendt as New Marketing Manager"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top